Yan X, Lu QG, Zeng L, Li XH, Liu Y, Du XF, Bai GM. Synergistic protection of astragalus polysaccharides and matrine against ulcerative colitis and associated lung injury in rats. World J Gastroenterol 2020; 26(1): 55-69 [PMID: 31933514 DOI: 10.3748/wjg.v26.i1.55]
Corresponding Author of This Article
Xin Yan, PhD, Professor, College of Traditional Chinese Medicine, North China University of Science and Technology, No. 21, Bohai Avenue, Caofeidian New Town, Tangshan 063210, Hebei Province, China. y18301212703@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Basic Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jan 7, 2020; 26(1): 55-69 Published online Jan 7, 2020. doi: 10.3748/wjg.v26.i1.55
Synergistic protection of astragalus polysaccharides and matrine against ulcerative colitis and associated lung injury in rats
Xin Yan, Qing-Ge Lu, Li Zeng, Xiao-Hai Li, Yu Liu, Xue-Feng Du, Guo-Min Bai
Xin Yan, College of Traditional Chinese Medicine, North China University of Science and Technology, Tangshan 063210, Hebei Province, China
Qing-Ge Lu, Li Zeng, Xiao-Hai Li, Yu Liu, Xue-Feng Du, Guo-Min Bai, Department of Anorectal Medicine, Tangshan Traditional Chinese Medicine Hospital, Tangshan 063000, Hebei Province, China
Author contributions: Yan X and Lu QG designed the research; Li XH and Liu Y performed the research; Zeng L and Bai GM analyzed the data; Du XF wrote the paper.
Supported byNational Natural Science Foundation of China, No. 81704059.
Institutional review board statement: This study was reviewed and approved by the North China University of Science and Technology Ethics Committee.
Institutional animal care and use committee statement: All procedures involving animals were reviewed and approved by the Institutional Animal Care and Use Committee of the North China University of Science and Technology.
Conflict-of-interest statement: The authors declare no conflict of interest.
Data sharing statement: No additional data are available.
ARRIVE guidelines statement: The authors have read the ARRIVE guidelines, and the manuscript was prepared and revised according to the ARRIVE guidelines.
Open-Access: This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Xin Yan, PhD, Professor, College of Traditional Chinese Medicine, North China University of Science and Technology, No. 21, Bohai Avenue, Caofeidian New Town, Tangshan 063210, Hebei Province, China. y18301212703@163.com
Received: November 11, 2019 Peer-review started: November 11, 2019 First decision: November 22, 2019 Revised: November 29, 2019 Accepted: December 14, 2019 Article in press: December 14, 2019 Published online: January 7, 2020 Processing time: 56 Days and 22 Hours
ARTICLE HIGHLIGHTS
Research background
Astragalus polysaccharides (APS) are bioactive components extracted from the radix of Astragalus membranaceus, a commonly used herbal compound in traditional Chinese medicine.
Research motivation
APS was reported to have anti-inflammatory, anti-oxidative, anti-tumor, and anti-diabetic properties.
Research objectives
To evaluate the therapeutic effect of APS and its potential mechanisms in a ulcerative colitis (UC) rat model induced by colon mucosal tissue sensitization combined with trinitro-benzene-sulfonic acid-ethanol.
Research methods
First, we used two groups of Wistar rats: UC models and controls. Then, 105 UC model rats were randomly divided to five groups: Model group (n = 25), salazopyrine control group (n = 25), APS treatment group (n = 15), matrine treatment group (n = 15), and monomer mixture group (n = 25).
Research results
The inflammatory response and oxidative stress injury was relieved in colitis observed in APS combined with matrine-treated mice.
Research conclusions
APS combined with matrine may represent a potential therapeutic approach for treating inflammatory bowel disease.
Research perspectives
Drug research can provide a valuable resource to help clinicians make strategic treatment choices that will ultimately benefit patients at many levels.